PAR-22-027 - Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release Date Expiration Date Activity Code(s)
Notice to Extend PAR-22-027, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)" NOT-DA-24-025 NIDA Apr 25, 2024 Apr 19, 2026 R21
Notice of Clarification to PAR-22-027, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)" NOT-DA-23-029 NIDA Jul 6, 2023 Apr 19, 2026 R21
Notice of NIDA Participation in NOT-MH-21-105, "Notice of Special Interest: Advancing Health Communication Research on HIV Prevention, Treatment and Cure" NOT-DA-21-079 NIDA Feb 16, 2022 Apr 19, 2026 R21, R01, R34, DP1, DP2, R03

Expired NOSIs

Title Notice Number Organization Release Date Expiration Date Activity Code(s)
Notice of Special Interest (NOSI): Firearm Injury and Mortality Prevention Research NOT-OD-23-039 OBSSR, NCCIH, NIA, NIAAA, NICHD, NIDA, NIMH, NIMHD, NINR, ODP, ORWH Dec 16, 2022 Sep 9, 2025 R01, R34, R21, U24, R61/R33, UG3/UH3
Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People NOT-OD-22-166 OD, NCCIH, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIMH, NIMHD, NINDS, ODP Aug 11, 2022 May 8, 2025 K24, U01, R01, K01, R15, R03, K76, R34, K99/R00, T32, F32, UG3/UH3, R21, K23, F31

For technical issues E-mail OER Webmaster